The AAFPRS is warning patients about the health dangers of counterfeit neuromodulators following FDA actions against companies selling unauthorized botulinum toxin products.
The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) is warning patients about the rising presence of counterfeit and unauthorized neuromodulators on the market, following recent enforcement action by the U.S. Food and Drug Administration.
FDA Targets Unauthorized Botulinum Toxin Products
The FDA issued warning letters to more than a dozen companies in the U.S. and abroad for selling unapproved versions of botulinum toxin type A, a neurotoxin used to temporarily relax facial muscles and reduce wrinkles. In response, the AAFPRS cautions that such products can pose serious health risks.
“As counterfeit injectable products continue to surface, it’s imperative for patients to prioritize their safety,” said Anthony E. Brissett, MD, FACS, president of the AAFPRS. “Anyone considering cosmetic treatments should take care to seek out medically trained professionals who use only properly handled, FDA-approved medications.”
Health Risks of Counterfeit and Improper Use
Counterfeit neuromodulators may be contaminated, improperly formulated, or completely ineffective, potentially exposing patients to hazardous substances and unpredictable outcomes.
Even when using authentic products, improper injection techniques by untrained individuals can lead to serious complications. These include nerve damage, drooping facial muscles, asymmetry, breathing problems, and even blindness.
The AAFPRS also warns against DIY injections at home. Even when using genuine product, incorrect administration can cause nerve injury, damage to blood vessels, or impact critical muscles responsible for functions such as blinking or swallowing.
Recommendations for Patients
Patients are advised to verify the credentials of any provider performing cosmetic injections. The AAFPRS recommends seeking care from board-certified physicians specializing in facial plastic surgery, dermatology, or other relevant specialties.
Patients should also request to see the medication vial and packaging, checking for proper labeling, expiration dates, and sourcing from licensed distributors.
Neuromodulators should never be purchased online for self-injection, regardless of cost. The health risks posed by counterfeit or mishandled toxins can be severe and long-lasting.
Reporting and Safety Measures
The AAFPRS advises consumers to report any suspicious injectable products or providers lacking proper credentials to state medical boards and the FDA through its MedWatch reporting system.
Patients experiencing unusual symptoms after receiving injections should seek immediate medical attention to help prevent complications and protect others from potential harm.
Photo: ID 84962469 © Scyther5 | Dreamstime.com
